The analysis reveals a strong dominance of AI applications in oncology, comprising 72.8% of all included studies. This skew ...

The pivotal trial for Neurogene's Rett syndrome gene therapy makes use of baseline controls and a rigorous endpoint that ...

I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced publication of the ...

Compass Pathways' Phase 3 COMP-360 data met primary endpoints but disappointed vs analyst expectations. See why investors ...

New trial results reveal zanzalintinib and atezolizumab significantly enhance survival in metastatic colorectal cancer, ...

One year of treatment with dapirolizumab pegol reduced fatigue and disease activity in people with SLE in a Phase 3 trial.

Robin Shackleford, D-Indianapolis, who wrote the clinical trial patient reimbursement bill, said there were plenty of wins for consumers, but some new laws will put people at a disadvantage, such ...

Here are some common barriers to clinical trial participation — and potential work-arounds you may be able to implement with the help of your care team. Challenge 1: Strict Eligibility Criteria ...

His experiment laid the foundation for modern clinical trials—structured studies on humans to assess the safety and effectiveness of treatments, vaccines, or preventive interventions.

CCCC's valuation is unjustifiably low, trading at half its liquidity despite a promising pipeline and no imminent cash crisis. Click here to read my analysis.

Sometimes, there are ways to get access to treatments that are in late-phase clinical trials but not yet approved by the FDA. These are called compassionate use programs. In recent years, the FDA has ...